209 related articles for article (PubMed ID: 28573650)
1. Complete versus incomplete revascularization with drug-eluting stents for multi-vessel disease in stable, unstable angina or non-ST-segment elevation myocardial infarction: A meta-analysis.
Ando T; Takagi H; Grines CL
J Interv Cardiol; 2017 Aug; 30(4):309-317. PubMed ID: 28573650
[TBL] [Abstract][Full Text] [Related]
2. Impact of Clinical Presentation (Stable Angina Pectoris vs Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction vs ST-Elevation Myocardial Infarction) on Long-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.
Giustino G; Baber U; Stefanini GG; Aquino M; Stone GW; Sartori S; Steg PG; Wijns W; Smits PC; Jeger RV; Leon MB; Windecker S; Serruys PW; Morice MC; Camenzind E; Weisz G; Kandzari D; Dangas GD; Mastoris I; Von Birgelen C; Galatius S; Kimura T; Mikhail G; Itchhaporia D; Mehta L; Ortega R; Kim HS; Valgimigli M; Kastrati A; Chieffo A; Mehran R
Am J Cardiol; 2015 Sep; 116(6):845-52. PubMed ID: 26174605
[TBL] [Abstract][Full Text] [Related]
3. Complete versus incomplete revascularization in patients with multivessel coronary artery disease treated with drug-eluting stents.
Chang M; Ahn JM; Kim N; Lee PH; Roh JH; Yoon SH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
Am Heart J; 2016 Sep; 179():157-65. PubMed ID: 27595691
[TBL] [Abstract][Full Text] [Related]
4. Culprit-only versus multivessel or complete versus incomplete revascularization in patients with non-ST-segment elevation myocardial infarction and multivessel disease who underwent successful percutaneous coronary intervention using newer-generation drug-eluting stents.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Atherosclerosis; 2020 May; 301():54-64. PubMed ID: 32330691
[TBL] [Abstract][Full Text] [Related]
5. Complete and incomplete revascularization in non-ST segment myocardial infarction with multivessel disease: long-term outcomes of first- and second-generation drug-eluting stents.
Hsieh MJ; Chen CC; Lee CH; Wang CY; Chang SH; Chen DY; Yang CH; Tsai ML; Yeh JK; Ho MY; Hsieh IC
Heart Vessels; 2019 Feb; 34(2):251-258. PubMed ID: 30159655
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of complete revascularization using either angiography-guided or fractional flow reserve-guided drug-eluting stent implantation in non-culprit vessels in ST elevation myocardial infarction patients: insights from a study based on a systematic review and meta-analysis.
Hideo-Kajita A; Garcia-Garcia HM; Kuku KO; Beyene SS; Azizi V; Meirovich YF; Melaku GD; Dheendsa A; Brathwaite EJ; Desale S; Soud M; Dan K; Ozaki Y; Waksman R; Lipinski M
Int J Cardiovasc Imaging; 2018 Sep; 34(9):1349-1364. PubMed ID: 29779179
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of complete versus incomplete revascularization for patients with multivessel coronary artery disease and left ventricular systolic dysfunction in drug-eluting stent era.
Sohn GH; Yang JH; Choi SH; Song YB; Hahn JY; Choi JH; Gwon HC; Lee SH
J Korean Med Sci; 2014 Nov; 29(11):1501-6. PubMed ID: 25408581
[TBL] [Abstract][Full Text] [Related]
8. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
[TBL] [Abstract][Full Text] [Related]
9. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials.
Sabaté M; Räber L; Heg D; Brugaletta S; Kelbaek H; Cequier A; Ostojic M; Iñiguez A; Tüller D; Serra A; Baumbach A; von Birgelen C; Hernandez-Antolin R; Roffi M; Mainar V; Valgimigli M; Serruys PW; Jüni P; Windecker S
JACC Cardiovasc Interv; 2014 Jan; 7(1):55-63. PubMed ID: 24332419
[TBL] [Abstract][Full Text] [Related]
10. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography.
Gonzalo N; Barlis P; Serruys PW; Garcia-Garcia HM; Onuma Y; Ligthart J; Regar E
JACC Cardiovasc Interv; 2009 May; 2(5):445-52. PubMed ID: 19463469
[TBL] [Abstract][Full Text] [Related]
11. Sex-related impact on clinical outcomes of patients treated with drug-eluting stents according to clinical presentation: Patient-level pooled analysis from the GRAND-DES registry.
Shin ES; Jun EJ; Han JK; Kong MG; Kang J; Zheng C; Garg S; Choi YJ; Bae JW; Chun KJ; Kim DI; Rha SW; Lee SY; Rhew JY; Woo SI; Lee HC; Jeong JO; Yang HM; Park KW; Kang HJ; Koo BK; Chae IH; Kim HS
Cardiol J; 2023; 30(1):105-116. PubMed ID: 33634845
[TBL] [Abstract][Full Text] [Related]
12. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
[TBL] [Abstract][Full Text] [Related]
13. Impact of Complete Revascularization on Six-Year Clinical Outcomes and Incidence of Acute Decompensated Heart Failure in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease.
Ahn MJ; Kim MC; Ahn Y; Sim DS; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC
Am J Cardiol; 2018 Mar; 121(5):544-551. PubMed ID: 29325904
[TBL] [Abstract][Full Text] [Related]
14. Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) Trials.
Damman P; van Geloven N; Wallentin L; Lagerqvist B; Fox KA; Clayton T; Pocock SJ; Hirsch A; Windhausen F; Tijssen JG; de Winter RJ
JACC Cardiovasc Interv; 2012 Feb; 5(2):191-9. PubMed ID: 22361604
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of complete versus incomplete revascularization after drug-eluting stent implantation in patients with multivessel coronary disease.
Gao Z; Xu B; Yang YJ; Yuan JQ; Chen J; Chen JL; Qiao SB; Wu YJ; Yan HB; Gao RL
Catheter Cardiovasc Interv; 2013 Sep; 82(3):343-9. PubMed ID: 23554306
[TBL] [Abstract][Full Text] [Related]
16. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial.
Vink MA; Dirksen MT; Suttorp MJ; Tijssen JG; van Etten J; Patterson MS; Slagboom T; Kiemeneij F; Laarman GJ
JACC Cardiovasc Interv; 2011 Jan; 4(1):24-9. PubMed ID: 21251625
[TBL] [Abstract][Full Text] [Related]
17. Outcomes and complications with off-label use of drug-eluting stents: results from the STENT (Strategic Transcatheter Evaluation of New Therapies) group.
Brodie BR; Stuckey T; Downey W; Humphrey A; Bradshaw B; Metzger C; Hermiller J; Krainin F; Juk S; Cheek B; Duffy P; Smith H; Edmunds J; Varanasi J; Simonton CA;
JACC Cardiovasc Interv; 2008 Aug; 1(4):405-14. PubMed ID: 19463338
[TBL] [Abstract][Full Text] [Related]
18. Long-term clinical outcomes in patients with unstable angina undergoing percutaneous coronary interventions in a contemporary registry data from Poland.
Piątek Ł; Janion-Sadowska A; Piątek K; Zandecki Ł; Zabojszcz M; Siudak Z; Sadowski M
Coron Artery Dis; 2020 May; 31(3):215-221. PubMed ID: 31821194
[TBL] [Abstract][Full Text] [Related]
19. Comparison of outcomes after percutaneous coronary intervention among different coronary subsets (stable and unstable angina pectoris and ST-segment and non-ST-segment myocardial infarction).
Loh JP; Pendyala LK; Kitabata H; Torguson R; Omar A; Minha S; Chen F; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2014 Jun; 113(11):1794-801. PubMed ID: 24837256
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes of patients receiving zotarolimus-eluting stents in ST elevation myocardial infarction, non-ST elevation acute coronary syndrome, and stable angina: data from the Resolute program.
Widimsky P; Motovska Z; Belardi J; Serruys P; Silber S; Windecker S; Neumann FJ
Int J Cardiol; 2013 Oct; 168(4):3522-6. PubMed ID: 23706326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
